ISSCR News
Call for Abstracts and Registration Are Open for ISSCR 2023 Annual Meeting 14-17 June 2023
Abstracts and registration are open for the ISSCR 2023 Annual Meeting, the most comprehensive gathering of scientists in stem cell research and regenerative medicine in the world. Taking place 14-17 June 2023 in Boston, USA, a global powerhouse for biomedical innovation, this hallmark event, co-sponsored by BlueRock Therapeutics, offers attendees opportunities for scientific exchange and relationship building for an unparalleled experience that showcases the year’s most compelling stem cell research and clinical breakthroughs.
Stem cells provide a model to understand sensorineural hearing loss
Disabling hearing loss affects one in every ten people and up to 25% of people over 60, according to the World Health Organization. Sensorineural hearing loss, the most frequent form of hearing loss, is caused by damage to specialized cells in the cochlea called hair cells (HCs) and spiral ganglion neurons (SGNs), respectively, both of which are essential for hearing. According to the authors of a recent paper published in Stem Cell Reports, researchers have generated “cochlear organoids with functional synapses for the first time, which provides a platform for deciphering the mechanisms of sensorineural hearing loss,” opening up avenues for investigating new therapeutic approaches.
ISSCR Convenes Task Force on Public Engagement; Adds Session to Annual Meeting
The ISSCR has expanded programming at the 2023 annual meeting to include a new Policy, Ethics, and Standards concurrent track at the society’s hallmark event taking place 14-17 June 2023 in Boston, USA. The new programming offers attendees an opportunity to learn more and offer feedback on the society’s initiatives including the newly formed Public Engagement Task Force, chaired by Robin Lovell-Badge, Francis Crick Institute, UK.
Member Spotlight: Brian Aguado, PhD
“[Being a part of the] Lawrence Goldstein Science Policy Fellowship continues my advocacy work and helps enact policy to fully incorporate sex as a biological variable in stem cell research, from basic scientific discovery to clinical trial”.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .